Navigation Links
Omnicare Pays Nearly $100 Million to Resolve Medicaid Fraud Charges: Second Omnicare Settlement With Chicago Whistleblower Pharmacist
Date:11/3/2009

ments.

Other Medicaid fraud and kickback charges settled today included: (1) claims that Omnicare paid $50 million to secure long-term contracts with certain nursing home chains; (2) claims that Omnicare had accepted $8 million in payments for promoting drugs from Ivax Pharmaceuticals Inc., a generic drug manufacturer; and (3) claims that Omnicare had provided consultant pharmacist services to nursing homes below fair market value in order to secure contracts from the nursing homes.
   
The settlement agreement and other court documents can be found on the reference website www.PharmacyFraudSettlement.com.

Today's settlement resulted from "qui tam" suits filed under the False Claims Act. The False Claims Act allows private citizens with knowledge of fraud, known as "relators," to help the government recover ill-gotten gains. False Claims Acts allow the government to collect up to three times the amount defrauded, in addition to civil penalties. Behn noted that qui tam relators can receive between 15 and 30 percent of the government's recovery.

Today's settlement was achieved through the efforts of Senior Trial Attorney Laurie A. Oberembt of the U.S. Department of Justice, Assistant U.S. Attorney Gregg Shapiro of Massachusetts, as well as a team from the National Association of Medicaid Fraud Units including Assistant Attorney General Keesha Mitchell of Ohio, Bureau Chief Patrick Keenan of the Illinois Attorney General's Office Medicaid Fraud Bureau, Assistant Attorney General Robert Patten of Massachusetts, and Assistant Attorney General Susan Aranella of Texas.

The Omnicare settlement is yet another successful whistleblower action handled by Behn & Wyetzner, Chartered for qui tam relators in the U.S. District Court for the Northern District of Illinois. Earlier this year,
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4 5

Related medicine news :

1. Detroit Area Hospitals Seek $75 Million from United American HealthCare Arising out of its Management of the Liquidated OmniCare HMO
2. National Pharmacy Omnicare Pays 'Unusual' Settlement to Resolve Charges of Generic Drug Switching in Delaware Nursing Homes, Resulting From 'Qui Tam' Lawsuit
3. ReBuilder Medical Technologies, Inc. Reports Monthly Sales in 2007 Nearly Doubling Monthly Sales in 2006, Including Record Daily Sales in September 2007
4. Nearly 30 Percent of Realtors(R) Lack Health Insurance
5. New Poll Finds Nearly Seven in 10 New Jersey Voters Support Smoke-Free Casinos
6. New Pharmaceutical Sales Force Communication Metrics: Nearly 6 Weeks of Sales Time per Rep Wasted Each Year
7. Anticancer Drugs Targeting the ErbB (EGFr/HEr2) Pathway Alone Generated Global Sales of Nearly $5 Billion in the First Nine Months of 2007
8. K-State Researchers Predict That an Outbreak of Foot-And-Mouth Disease Could Cost Kansas Nearly a Billion Dollars
9. Smokers Cost Medicaid System Nearly $10 Billion
10. Research Indicates Nearly 25 Percent of Supplements Are Contaminated With Steroids, Stimulants and Banned Substances
11. Cipla Offers Modest AIDS Drug Price Cut: Not Nearly Enough, says AHF

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Omnicare Pays Nearly $100 Million to Resolve Medicaid Fraud Charges: Second Omnicare Settlement With Chicago Whistleblower Pharmacist 
Omnicare Pays Nearly $100 Million to Resolve Medicaid Fraud Charges: Second Omnicare Settlement With Chicago Whistleblower Pharmacist
(Date:11/27/2009)...es may reduce future disease burden, researchers s...-- Encouraging city dwellers to walk and bicycle i...ic health benefits than increased used of low-emis...he study compared the projected health effects in ... for London, England, and Delhi, India: business-...
(Date:11/27/2009)...e; announced today that Spectrum Health (Grand Rap...se orthopedic templating solution and its TraumaCa... (PRWEB) November 27, 2009 -- Voyant Health&tr...apids, Michigan) has licensed its TraumaCad Enterp...Cad Extend workflow solution, to allow its orthope...
(Date:11/27/2009)...ive anatomy education apps from Modality and Lippi...s learning opportunities for iPhone and iPod touch...ember 27, 2009 -- Modality, Inc. and Lippincott ...s Kluwer Health, today announced the availability ...re. Clemente’s Anatomy, Rohen’s Photog...
(Date:11/26/2009)...ans living with diabetes will nearly double, incre... 2034. Over the same period, spending on diabetes ...36 billion, even with no increase in the prevalenc...of Chicago report in the December issue of Diabet...vered by Medicare will rise from 8.2 million to 14...
(Date:11/26/2009)...l rollercoaster, study finds , , THURSDA...ctor meets the jubilant sports fan. , A new stu...o root for the winning team -- enjoy the greatest ... victory was in doubt, producing feelings of worry...ving weekend as you,re glued to the TV set, watchi...
Breaking Medicine News(10 mins):Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3
...al Corporation,(OTC Bulletin Board: CONX), a world...s, reported sales of $2,001,896 for the first fisc... $2,105,188 for the quarter,ended September 30, 20... The first quarter of fiscal 2009 produced an oper...
...orts and,Nutritional Supplements developer and man...TNI) announced today that the company,s primary op...ional, Inc. (INII) has signed a,five year exclusiv...urdur Arnason. The contract calls for minimum,purc...
...utical Company,(NYSE: KVa ; KVb) announced that i...Commission a Form 12b-25 notification that its Qua...eptember 30, 2008 will be delayed., About KV Phar...ires,technology-distinguished branded and generic/...
...e the majority of employers believe the best way t...overhaul, they are confident that the U.S. should ...ystem. , Brookfield, Wisc...hey are confident that the U.S. should not move aw...
...cent innovation in laser skin treatments combines ...ent Dual Mode RF System uses unipolar and bipolar ...n both shallow and deep tissue depths. The technol...WEB) November 13, 2008 -- A new skin rejuvenation...
...uest Biosciences, Inc. a,development stage pain ma...d and Drug Administration (FDA) has accepted its I...-1015, its abuse deterrent extended release,strong...cer of TheraQuest stated,"Sustained release opioid...
Other Medicine News:Health News:Corgenix Reports Financial Results for First Quarter of Fiscal 2009 2Health News:Corgenix Reports Financial Results for First Quarter of Fiscal 2009 3Health News:Natural Nutrition Canadian Subsidiary Signs $50.5 Million (CDN) Five Year European Distribution Contract 2Health News:KV Pharmaceutical Company Files Form Reporting Delay in Filing Second Quarter Form 10-Q 2Health News:KV Pharmaceutical Company Files Form Reporting Delay in Filing Second Quarter Form 10-Q 3Health News:KV Pharmaceutical Company Files Form Reporting Delay in Filing Second Quarter Form 10-Q 4Health News:Employers Want National Approach to Health Care—Still Believe Employer-Based System Works Best: New Survey Looks At Attitudes toward Health Care Reform and Major Health Care Issues. 2Health News:Employers Want National Approach to Health Care—Still Believe Employer-Based System Works Best: New Survey Looks At Attitudes toward Health Care Reform and Major Health Care Issues. 3Health News:Accent Dual Mode Skin Tightening Laser is Latest Offering from Juva Skin Center 2Health News:TheraQuest's IND for Abuse Deterrent Strong Opioid (TQ-1015) Accepted by FDA 2
(Date:11/25/2009)..., , RANCHO CORDOVA, Calif., Nov. 25 /PRNews...ary of American Pacific Corporation (Nasdaq: APFC...tal Responsibility and Sustainability Award at the...by the California Manufacturers and Technology Ass...ciation (IEA) and the Chemical Industry Council of...
(Date:11/25/2009)..., , NEW YORK, Nov. 25 ...arch report is available in its catalogue: ,, ...ve ,, http://www.reportlinker.com/p0164330/M....html ,, Rising incidence of breast cancer in ...principal factor influencing growth in the mammogr...
(Date:11/25/2009)..., , SAN DIEGO, Nov. 25 /PRNewswire-...edical device company focused on developing produc...r the spine, announced today that it will host a c...30 p.m. ET / 2:30 p.m. PT. The conference call wi...nt for the Company,s products and will include com...
Breaking Medicine Technology:AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7Reportlinker Adds Mammography Equipment - A Global Market Perspective 8NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3NuVasive Announces Conference Call and Webcast Regarding Reimbursement 4Arena Pharmaceuticals to Present at the UBS Global Life Sciences Conference 14150 1Arena Pharmaceuticals to Present at the UBS Global Life Sciences Conference 14150 2Arena Pharmaceuticals to Present at the UBS Global Life Sciences Conference 14150 3Cheap quick bedside eye movement exam outperforms MRI for diagnosing stroke in patients 57673 1Cheap quick bedside eye movement exam outperforms MRI for diagnosing stroke in patients 57673 2Cheap quick bedside eye movement exam outperforms MRI for diagnosing stroke in patients 57673 3Guatemala Treatment Center Becomes First in Latin America to Introduce Fast and Precise RapidArc Radiotherapy Cancer Treatments 57669 1Guatemala Treatment Center Becomes First in Latin America to Introduce Fast and Precise RapidArc Radiotherapy Cancer Treatments 57669 2
...search reflects depth and breadth of, collaborati...atments for diverse forms o...f Zometa(R), the leading IV, bisphosphonate, on re...cer, - Four oral sessions to feature RAD001, firs...ncluding first results of RECORD-1 study in renal ...
...ith a newly cleared device to identify the, lipid...e associated with complications ...InfraReDx, Inc. today,announced that physicians at...ssfully used its LipiScan(TM) Coronary Imaging Sys...ion. This is the first patient in the,world in who...
Other Medicine Technology:Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 2Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 3Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 4Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 5Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 6Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 7Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 8Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 9Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 10First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 2First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 3First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 4
...trade; RT cannulas are all able to be used with th...RT system. , ,The VERSAPORT™ RT cannulas ar...ms packaged for use with the RT system. The trocar...ade; Plus V2, SURGISPIKE™ (5mm only, no dila...
VERSAPORT™ Plus RT Single Use Obturators
SURGISPIKE™ Non-Shielded Single Use 5 mm Trocar
...e™ SPRING-GRIP™ single use nonconducti... 11 mm and 12 mm sizes for use with the SURGIPORT&... mm-11 mm, 5 mm-12 mm and 10 mm-15 mm sizes for us...EMIUM SURGIPORT™, SURGIPORT™ III and V...
Medicine Products: